Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05506449 · ClinicalTrials.gov registry record · NA
The RECOVER IV Trial
A NA study, sponsored by Abiomed.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05506449: Clinical Trial NA study, sponsored by Abiomed.
NCT05506449 is a NA study that was terminated before completion, run by Abiomed. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05506449, a NA study, was terminated before completion, sponsored by Abiomed.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether hemodynamic support with an Impella-based treatment strategy initiated prior to percutaneous coronary intervention (PCI) in patients with ST-Segment Elevation Myocardial Infarction (STEMI)-Cardiogenic Shock (CS) improves survival and functional outcomes compared to a non-Impella-based treatment strategy.
Interventions
- OTHER Standard of Care
- DEVICE Impella CP®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2023-10-28 |
| Est. Completion | 2024-12-06 |
| Phase | NA |
Why NCT05506449 stopped before completion
NCT05506449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT05506449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05506449 about?
NCT05506449 is a clinical study titled "The RECOVER IV Trial". The purpose of this study is to assess whether hemodynamic support with an Impella-based treatment strategy initiated prior to percutaneous coronary intervention (PCI) in patients with ST-Segment Elevation Myocardial Infarction (STEMI)-Cardiogenic Shock (CS) improves survival and functional outcomes...
What is the current status of trial NCT05506449?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2023-10-28. Estimated completion is 2024-12-06.
What interventions are being tested in trial NCT05506449?
The interventions under investigation include: Standard of Care (OTHER), Impella CP® (DEVICE).
Who is sponsoring clinical trial NCT05506449?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05506449's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI